Antibody-dependent Cellular Cytotoxicity in HIV Infection

Overview

Journal AIDS

Specialty Infectious Diseases

Date 2018 Sep 21

PMID 30234611

Citations 56

Authors

Donald N Forthal

Andres Finzi

Affiliations

Soon will be listed here.

Abstract

: Interactions between the Fc segment of IgG and its receptors (FcγRs) found on cells such as natural killer cells, monocytes, macrophages and neutrophils can potentially mediate antiviral effects in the setting of HIV and related infections. We review the potential role of FcγR interactions in HIV, SIV and SHIV infections, with an emphasis on antibody-dependent cellular cytotoxicity (ADCC). Notably, these viruses employ various strategies, including CD4 down-regulation and BST-2/tetherin antagonism to limit the effect of ADCC. Although correlative data suggest that ADCC participates in both protection and control of established infection, there is little direct evidence in support of either role. Direct evidence does, however, implicate an FcγR-dependent function in augmenting the beneficial in vivo activity of neutralizing antibodies.

Citing Articles

NK cell depletion in bispecific antibody therapy is associated with lack of HIV control after ART interruption.

Sanchez-Gaona N, Perea D, Curran A, Burgos J, Navarro J, Suanzes P Commun Biol. 2025; 8(1):236.

PMID: 39953264 PMC: 11829058. DOI: 10.1038/s42003-025-07651-6.

Immune-mediated strategies to solving the HIV reservoir problem.

Kulpa D, Paiardini M, Silvestri G Nat Rev Immunol. 2025; .

PMID: 39948261 DOI: 10.1038/s41577-025-01136-7.

Novel oral adjuvant to enhance cytotoxic memory like NK cell responses in HIV vaccine platform.

Alles M, Gunasena M, Isckarus C, De Silva I, Board S, Mulhern W NPJ Vaccines. 2025; 10(1):5.

PMID: 39799133 PMC: 11724931. DOI: 10.1038/s41541-024-01053-1.

Mucosal immune response in biology, disease prevention and treatment.

Zhou X, Wu Y, Zhu Z, Lu C, Zhang C, Zeng L Signal Transduct Target Ther. 2025; 10(1):7.

PMID: 39774607 PMC: 11707400. DOI: 10.1038/s41392-024-02043-4.

30 years of HIV therapy: Current and future antiviral drug targets.

Nuwagaba J, Li J, Ngo B, Sutton R Virology. 2024; 603:110362.

PMID: 39705895 PMC: 11788039. DOI: 10.1016/j.virol.2024.110362.

References

Parsons M, Loh L, Gooneratne S, Center R, Kent S . Role of education and differentiation in determining the potential of natural killer cells to respond to antibody-dependent stimulation. AIDS. 2014; 28(18):2781-6. DOI: 10.1097/QAD.0000000000000489. View

Lanier L . Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol. 2008; 9(5):495-502. PMC: 2669298. DOI: 10.1038/ni1581. View

Bruhns P, Jonsson F . Mouse and human FcR effector functions. Immunol Rev. 2015; 268(1):25-51. DOI: 10.1111/imr.12350. View

Smalls-Mantey A, Connors M, Sattentau Q . Comparative efficiency of HIV-1-infected T cell killing by NK cells, monocytes and neutrophils. PLoS One. 2013; 8(9):e74858. PMC: 3769266. DOI: 10.1371/journal.pone.0074858. View

Van Rompay K, Berardi C, Tarara R, Canfield D, Valverde C, Montefiori D . Passive immunization of newborn rhesus macaques prevents oral simian immunodeficiency virus infection. J Infect Dis. 1998; 177(5):1247-59. DOI: 10.1086/515270. View

Madhavi V, Wines B, Amin J, Emery S, Lopez E, Kelleher A . HIV-1 Env- and Vpu-Specific Antibody-Dependent Cellular Cytotoxicity Responses Associated with Elite Control of HIV. J Virol. 2017; 91(18). PMC: 5571238. DOI: 10.1128/JVI.00700-17. View

Taylor A, Foo S, Bruzzone R, Dinh L, King N, Mahalingam S . Fc receptors in antibody-dependent enhancement of viral infections. Immunol Rev. 2015; 268(1):340-64. PMC: 7165974. DOI: 10.1111/imr.12367. View

Bournazos S, Klein F, Pietzsch J, Seaman M, Nussenzweig M, Ravetch J . Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity. Cell. 2014; 158(6):1243-1253. PMC: 4167398. DOI: 10.1016/j.cell.2014.08.023. View

Tomescu C, Mavilio D, Montaner L . Lysis of HIV-1-infected autologous CD4+ primary T cells by interferon-alpha-activated NK cells requires NKp46 and NKG2D. AIDS. 2015; 29(14):1767-73. PMC: 4571461. DOI: 10.1097/QAD.0000000000000777. View

10.

Pham T, Lukhele S, Hajjar F, Routy J, Cohen E . HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2. Retrovirology. 2014; 11:15. PMC: 3930549. DOI: 10.1186/1742-4690-11-15. View

11.

Orlikowsky T, Wang Z, Dudhane A, Dannecker G, Niethammer D, Wormser G . Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected persons. J Infect Dis. 2001; 184(10):1328-30. DOI: 10.1086/323997. View

12.

Siegel F, Kurth R, Norley S . Neither whole inactivated virus immunogen nor passive immunoglobulin transfer protects against SIVagm infection in the African green monkey natural host. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 8(3):217-26. DOI: 10.1097/00042560-199503010-00001. View

13.

Ma X, Lu M, Gorman J, Terry D, Hong X, Zhou Z . HIV-1 Env trimer opens through an asymmetric intermediate in which individual protomers adopt distinct conformations. Elife. 2018; 7. PMC: 5896952. DOI: 10.7554/eLife.34271. View

14.

Fouts T, Bagley K, Prado I, Bobb K, Schwartz J, Xu R . Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection. Proc Natl Acad Sci U S A. 2015; 112(9):E992-9. PMC: 4352796. DOI: 10.1073/pnas.1423669112. View

15.

Tokarev A, Stoneham C, Lewinski M, Mukim A, Deshmukh S, Vollbrecht T . Pharmacologic Inhibition of Nedd8 Activation Enzyme Exposes CD4-Induced Epitopes within Env on Cells Expressing HIV-1. J Virol. 2015; 90(5):2486-502. PMC: 4810708. DOI: 10.1128/JVI.02736-15. View

16.

Wren L, Parsons M, Isitman G, Center R, Kelleher A, Stratov I . Influence of cytokines on HIV-specific antibody-dependent cellular cytotoxicity activation profile of natural killer cells. PLoS One. 2012; 7(6):e38580. PMC: 3372512. DOI: 10.1371/journal.pone.0038580. View

17.

Orlandi C, Flinko R, Lewis G . A new cell line for high throughput HIV-specific antibody-dependent cellular cytotoxicity (ADCC) and cell-to-cell virus transmission studies. J Immunol Methods. 2016; 433:51-8. PMC: 4869150. DOI: 10.1016/j.jim.2016.03.002. View

18.

Hessell A, Shapiro M, Powell R, Malherbe D, McBurney S, Pandey S . Reduced Cell-Associated DNA and Improved Viral Control in Macaques following Passive Transfer of a Single Anti-V2 Monoclonal Antibody and Repeated Simian/Human Immunodeficiency Virus Challenges. J Virol. 2018; 92(11). PMC: 5952134. DOI: 10.1128/JVI.02198-17. View

19.

Baba T, Liska V, Hofmann-Lehmann R, Vlasak J, Xu W, Ayehunie S . Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med. 2000; 6(2):200-6. DOI: 10.1038/72309. View

20.

Homsy J, Meyer M, Tateno M, Clarkson S, Levy J . The Fc and not CD4 receptor mediates antibody enhancement of HIV infection in human cells. Science. 1989; 244(4910):1357-60. DOI: 10.1126/science.2786647. View